-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Upgrades Inspire Medical Systems to Outperform, Announces $175 Price Target

Benzinga·12/08/2025 13:50:59
Listen to the news
Oppenheimer analyst Suraj Kalia upgrades Inspire Medical Systems (NYSE:INSP) from Perform to Outperform and announces $175 price target.